Isolated serum hepatitis B core antibody seropositivity: A diagnostic risk factor for occult hepatitis B infection-Reference-Cited by-同舟云学术

Isolated serum hepatitis B core antibody seropositivity: A diagnostic risk factor for occult hepatitis B infection

Published:2019-11-14 Issue:2 Volume:15 Page:266-272
ISSN:1751-2816
Container-title:ISBT Science Series
language:en
Short-container-title:VOXS

Author:

Fasakin Kolawole A.¹,Ifeanyichukwu Martin O.²,Ibijola Ajayi Adeleke³,Adeniyi Augustine A.⁴,Ajetunmobi Wasiu A.⁵,Adebara Idowu O.⁴,Ajayi Oluwafemi David⁶^ORCID,Esan Ayodele Jacob⁷,Oyeleke Kikelomo O.⁸,Omisakin Christopher T.⁹

Affiliation:

1. Blood Transfusion Laboratory Department of Haematology Federal Teaching Hospital Ido Ekiti Nigeria

2. Department of Medical Laboratory Science Faculty of Health Sciences and Technology Nnamdi Azikiwe University Nnewi Campus Nigeria

3. Department of Haematology Federal Teaching Hospital Ido Ekiti Nigeria

4. Department of Obstetrics and Gynaecology Federal Teaching Hospital Ido Ekiti Nigeria

5. Department of Paediatrics Federal Teaching Hospital Ido Ekiti Nigeria

6. Blood Transfusion Laboratory ABUAD Multi‐System Hospital Ado Ekiti Nigeria

7. General Haematology Laboratory Department of Haematology Federal Teaching Hospital Ido Ekiti Nigeria

8. Department of Medical Laboratory Science Kwara State University Ilorin Nigeria

9. ART Laboratory Department of Haematology Federal Teaching Hospital Ido Ekiti Nigeria

Publisher

Wiley

Subject

Computer Networks and Communications,Hardware and Architecture,Software

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/voxs.12526

Reference52 articles.

1. International forum on Occult hepatitis B infection and transfusion safety

2. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

3. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?

4. World Health Organization:Guidelines on estimation of residual risk of HIV HBV or HCV infections via cellular blood components and plasma. WHO2015.

5. Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase